Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older
Clinical trial NCT05534048 · UNKNOWN
Trial details
- NCT number
- NCT05534048
- Sponsor
- Everest Medicines (Singapore) Pte. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-03
- Primary completion
- 2023-07-02
- Enrollment
- 3800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.